<DOC>
	<DOCNO>NCT01658618</DOCNO>
	<brief_summary>This observation safety study intend subject participate 802-247-09-029 study investigational product HP802-247 venous leg ulcer receive least one application HP802-247 Vehicle ( inactive substance ) . This study do follow purpose : 1. identify new adverse event , 2. examine ongoing adverse event resolve subject participate 802-247-09-029 trial , 3. record wound status , 4. determine difference Health Related Quality Life ( HRQoL ) associate treatment assignment 802-247-09-029 Trial . Investigational mean HP802-247 approve U.S. Food Drug Administration ( FDA ) .</brief_summary>
	<brief_title>Safety Study Providing 12 Months Follow-up From First Exposure HP802-247 Subjects With Venous Leg Ulcer</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Provide inform consent document Subject randomize 80224709029 receive least one application test article . Subject end participation 80224709029 virtue completing study , drop prior completion . Subjects refuse provide write informed consent exclude trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Venous leg ulcer</keyword>
	<keyword>ulcer</keyword>
	<keyword>venous stasis</keyword>
	<keyword>compression</keyword>
	<keyword>venous</keyword>
	<keyword>venous stasis ulcer</keyword>
	<keyword>vlu</keyword>
	<keyword>hp802-247-09-029</keyword>
</DOC>